Cigna’s Express Scripts pharmacy benefit
management unit and a PBM owned by 18 Blue Cross and Blue Shield plans have
joined forces to tame drug costs for a massive client list that covers 100
million people.
In an announcement Thursday night, Express Scripts and Prime Therapeutics said their new
three-year collaboration is “designed to deliver more affordable care for
clients and their members by enhancing pharmacy networks and pharmaceutical
manufacturer value.” The collaboration will allow Prime’s member Blue Cross
health plans to gain leverage through Express Scripts’ buying clout and large
pharmacy network.
The collaboration could put pressure on drug
makers that are already under fire for rising prescription costs at a time the
pharmaceutical industry is already taking heat and facing bipartisan legislation wending its
way through Congress that appears to have the support of the
Trump administration. PBMs are the middlemen between drug makers and patients
when it comes to purchasing drugs in bulk and leveraging their buying clout to
negotiate better discounts for consumers and employers on prescription drugs.
Prime is owned by 18 Blue Cross and Blue
Shield Plans, including Florida Blue and Health Care Service Corp., which owns
Blues plans in Illinois, Texas, Oklahoma, New Mexico and Montana.
Combined, Prime provides PBM services to more than 28 million people.
Meanwhile, Express Scripts said it has more than 3,000 clients and 75 million
customer relationships.
“Both companies will continue to work independently
with pharmaceutical manufacturers—Express Scripts handling negotiations for
drugs on the pharmacy benefit, and each company separately managing certain
relationships on the medical benefit and value-based contracting,” the
companies said in a joint statement. Financial terms of the collaboration
weren’t disclosed.
The deal comes amid an industry shakeup that
includes consolidation of PBMs with big health plans. The nation’s second
largest health insurer Anthem, which owns 14 Blue Cross and Blue Shield plans,
is rolling out its own PBM called IngenioRx. Meanwhile, CVS Health, which owns
the Caremark PBM, is gaining market share following its acquisition last year
of Aetna, the nation’s third-largest health insurer. And UnitedHealth Group,
the nation’s largest health insurer, owns the OptumRx PBM, which is also growing
rapidly.
"As health care costs continue to grow at
an unsustainable pace, improving the value we deliver in health care is
critical,” Prime Therapeutics chief executive Ken Paulus said in a statement
Thursday evening. ”This collaboration will improve outcomes while still
maintaining flexibility and transparency to the clients we proudly serve.”
Cigna’s Express Scripts said the collaboration
“will have an immaterial impact to adjusted income from operations in 2020
with a more positive contribution beginning in 2021.”
"Our agreement reinforces our position as
a health services partner of choice for health plans, employers, government and
other payers seeking the most value for their investments in health care,"
Express Scripts president Tim Wentworth said. "This collaboration allows
both Prime and Express Scripts to leverage our capabilities to deliver more
affordable health care."
No comments:
Post a Comment